Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TH-SC01 for Chronic Radiation Proctitis
NCT06438809Phase 2Recruiting
- Sponsor
- Jiangsu Tuohong Kangheng Pharmaceutical Co., Ltd.
- Start
- May 2024
- Primary completion
- May 2025
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of TH-SC01 in chronic radiation proctitis (CRP), sponsored by Jiangsu Tuohong Kangheng Pharmaceutical Co., Ltd.. Started May 2024; status: recruiting.
02
Drugs
TH-SC01
03
Conditions
chronic radiation proctitis (CRP)
Beyond the preview
Go deeper on NCT06438809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06438809.